This cohort study examines whether apolipoprotein B and lipoprotein(a), as emerging lipid biomarkers, are associated with atherosclerotic cardiovascular disease risk and with improved risk estimation beyond established models.
JAMA Network Open published a clinical update in Research Highlights on 07 Apr 2026.
The item focuses on Traditional and Emerging Lipid Markers for Cardiovascular Risk Assessment.
Review the original article for the full source wording and details.